Influence of HLA-C expression level on HIV control
- PMID: 23559252
- PMCID: PMC3784322
- DOI: 10.1126/science.1232685
Influence of HLA-C expression level on HIV control
Abstract
A variant upstream of human leukocyte antigen C (HLA-C) shows the most significant genome-wide effect on HIV control in European Americans and is also associated with the level of HLA-C expression. We characterized the differential cell surface expression levels of all common HLA-C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection in 5243 individuals. Increasing HLA-C expression was associated with protection against multiple outcomes independently of individual HLA allelic effects in both African and European Americans, regardless of their distinct HLA-C frequencies and linkage relationships with HLA-B and HLA-A. Higher HLA-C expression was correlated with increased likelihood of cytotoxic T lymphocyte responses and frequency of viral escape mutation. In contrast, high HLA-C expression had a deleterious effect in Crohn's disease, suggesting a broader influence of HLA expression levels in human disease.
Figures


Comment in
-
Comment on "Influence of HLA-C expression level on HIV control".Science. 2013 Sep 13;341(6151):1175. doi: 10.1126/science.1241266. Science. 2013. PMID: 24031002
-
Response to Comment on "Influence of HLA-C expression level on HIV control".Science. 2013 Sep 13;341(6151):1175. doi: 10.1126/science.1241854. Science. 2013. PMID: 24031003 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- U01-AI-35042/AI/NIAID NIH HHS/United States
- U01-AI-37613/AI/NIAID NIH HHS/United States
- R01-DA04334/DA/NIDA NIH HHS/United States
- K24AI069994/AI/NIAID NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- K08 AR057763/AR/NIAMS NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- HHSN261200800001C/RC/CCR NIH HHS/United States
- R01 AI046995/AI/NIAID NIH HHS/United States
- HHSN261200800001E/CA/NCI NIH HHS/United States
- R01-DA-04334/DA/NIDA NIH HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01 DA036297/DA/NIDA NIH HHS/United States
- R01-DA-12568/DA/NIDA NIH HHS/United States
- P30 MH062246/MH/NIMH NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- U01-AI-35043/AI/NIAID NIH HHS/United States
- 5-M01-RR-00722/RR/NCRR NIH HHS/United States
- U01 AI067854/AI/NIAID NIH HHS/United States
- R01 DA004334/DA/NIDA NIH HHS/United States
- K24 AI069994/AI/NIAID NIH HHS/United States
- U01 AI037613/AI/NIAID NIH HHS/United States
- U01-AI-35041/AI/NIAID NIH HHS/United States
- U01-AI-067854/AI/NIAID NIH HHS/United States
- M01 RR000722/RR/NCRR NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- R24 AI067039/AI/NIAID NIH HHS/United States
- R01-AI060460/AI/NIAID NIH HHS/United States
- R01 AI087145/AI/NIAID NIH HHS/United States
- R01 AR065174/AR/NIAMS NIH HHS/United States
- P30 AI027767-24/AI/NIAID NIH HHS/United States
- R01-DA12568/DA/NIDA NIH HHS/United States
- R01 AI060460/AI/NIAID NIH HHS/United States
- PG/09/077/27964/BHF_/British Heart Foundation/United Kingdom
- U01-AI-35040/AI/NIAID NIH HHS/United States
- K08AR057763/AR/NIAMS NIH HHS/United States
- P30 AI110527/AI/NIAID NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- U01-AI-37984/AI/NIAID NIH HHS/United States
- N02 CP055504/CP/NCI NIH HHS/United States
- R01-AI046995/AI/NIAID NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U01-AI-35039/AI/NIAID NIH HHS/United States
- P30 MH62246/MH/NIMH NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials